Kirsten Minden

Summary

Affiliation: German Rheumatism Research Centre
Country: Germany

Publications

  1. ncbi request reprint The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database
    K Minden
    German Rheumatism Research Centre, Berlin, Germany
    Clin Exp Rheumatol 27:863-9. 2009
  2. doi request reprint Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO
    Kirsten Minden
    German Rheumatism Research Centre Berlin, a Leibnitz Institute, Chariteplatz 1, 10117 Berlin, Germany
    Rheumatology (Oxford) 51:1407-15. 2012
  3. doi request reprint Adult outcomes of patients with juvenile idiopathic arthritis
    Kirsten Minden
    Children s University Hospital Charité Berlin and Epidemiology Unit, German Rheumatism Research Centre, Berlin DE 13353, Germany
    Horm Res 72:20-5. 2009
  4. doi request reprint [Transition from pediatric to adult rheumatological care]
    K Minden
    Programmbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin, Berlin, Deutschland
    Z Rheumatol 75:635-45. 2016
  5. doi request reprint [Immunization in children and adolescents with rheumatic and musculoskeletal diseases]
    K Minden
    Universitätskinderklinik Charité, Campus Virchow, Otto Heubner Centrum, SPZ, Deutsches Rheuma ForschungsZentrum Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland
    Z Rheumatol 73:878-89. 2014
  6. doi request reprint [Berlin transition program: from adolescents to adults in rheumatology treatment]
    K Minden
    Programmbereich Epidemiologie, Deutsches Rheuma Forschungszentrum Berlin und Universitätskinderklinik Charité, Campus Virchow SPZ, Chariteplatz 1, 10117, Berlin, Deutschland
    Z Rheumatol 73:526-31. 2014
  7. doi request reprint [Biologics register JuMBO. Long-term safety of biologic therapy of juvenile idiopathic arthritis]
    K Minden
    Deutsches Rheuma ForschungsZentrum Berlin, ein Institut der Leibnizgemeinschaft, Programmbereich Epidemiologie, Chariteplatz 1, 10117 Berlin
    Z Rheumatol 72:339-46. 2013
  8. ncbi request reprint [Juvenile idiopathic arthritis and uveitis: epidemiology including data from a national database]
    K Minden
    Deutsches Rheuma ForschungsZentrum Berlin, Chariteplatz 1, Berlin
    Klin Monbl Augenheilkd 224:469-72. 2007
  9. ncbi request reprint Long-term outcome in patients with juvenile idiopathic arthritis
    Kirsten Minden
    German Rheumatism Research Center, Berlin
    Arthritis Rheum 46:2392-401. 2002
  10. pmc Burden and cost of illness in patients with juvenile idiopathic arthritis
    K Minden
    Deutsches Rheuma ForschungsZentrum Berlin, Schumannstr 21 22, 10117 Berlin, Germany
    Ann Rheum Dis 63:836-42. 2004

Collaborators

Detail Information

Publications23

  1. ncbi request reprint The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database
    K Minden
    German Rheumatism Research Centre, Berlin, Germany
    Clin Exp Rheumatol 27:863-9. 2009
    ..To estimate the cost of juvenile idiopathic arthritis (JIA) and to evaluate the influence of specific disease characteristics on the various costs domains...
  2. doi request reprint Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO
    Kirsten Minden
    German Rheumatism Research Centre Berlin, a Leibnitz Institute, Chariteplatz 1, 10117 Berlin, Germany
    Rheumatology (Oxford) 51:1407-15. 2012
    ..To assess the outcome of adult patients with JIA who received etanercept (ETA) during childhood...
  3. doi request reprint Adult outcomes of patients with juvenile idiopathic arthritis
    Kirsten Minden
    Children s University Hospital Charité Berlin and Epidemiology Unit, German Rheumatism Research Centre, Berlin DE 13353, Germany
    Horm Res 72:20-5. 2009
    ..In contrast, localized growth disturbances can be seen in patients with oligoarthritis...
  4. doi request reprint [Transition from pediatric to adult rheumatological care]
    K Minden
    Programmbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin, Berlin, Deutschland
    Z Rheumatol 75:635-45. 2016
    ..There is emerging evidence of the effectiveness of transitional care programs. The implementation of a structured transition into the routine care of adolescents and young adults with rheumatic diseases is necessary. ..
  5. doi request reprint [Immunization in children and adolescents with rheumatic and musculoskeletal diseases]
    K Minden
    Universitätskinderklinik Charité, Campus Virchow, Otto Heubner Centrum, SPZ, Deutsches Rheuma ForschungsZentrum Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland
    Z Rheumatol 73:878-89. 2014
    ..However, approximately one in three patients with a juvenile rheumatic disease is nowadays still inadequately vaccinated, mostly due to uncertainty regarding the efficacy and safety of vaccination in these patients...
  6. doi request reprint [Berlin transition program: from adolescents to adults in rheumatology treatment]
    K Minden
    Programmbereich Epidemiologie, Deutsches Rheuma Forschungszentrum Berlin und Universitätskinderklinik Charité, Campus Virchow SPZ, Chariteplatz 1, 10117, Berlin, Deutschland
    Z Rheumatol 73:526-31. 2014
    ....
  7. doi request reprint [Biologics register JuMBO. Long-term safety of biologic therapy of juvenile idiopathic arthritis]
    K Minden
    Deutsches Rheuma ForschungsZentrum Berlin, ein Institut der Leibnizgemeinschaft, Programmbereich Epidemiologie, Chariteplatz 1, 10117 Berlin
    Z Rheumatol 72:339-46. 2013
    ..Data from BiKeR and JuMBO contribute to the risk-benefit assessment of biologic drugs which have been implemented in the routine treatment of JIA...
  8. ncbi request reprint [Juvenile idiopathic arthritis and uveitis: epidemiology including data from a national database]
    K Minden
    Deutsches Rheuma ForschungsZentrum Berlin, Chariteplatz 1, Berlin
    Klin Monbl Augenheilkd 224:469-72. 2007
    ..Due to the usual lack of symptoms the diagnosis of uveitis requires, however, an examination by an ophthalmologist. This should be done immediately after the diagnosis of JIA and repeated in a risk-adapted manner during the follow-up...
  9. ncbi request reprint Long-term outcome in patients with juvenile idiopathic arthritis
    Kirsten Minden
    German Rheumatism Research Center, Berlin
    Arthritis Rheum 46:2392-401. 2002
    ..To describe the long-term outcome of juvenile idiopathic arthritis (JIA)...
  10. pmc Burden and cost of illness in patients with juvenile idiopathic arthritis
    K Minden
    Deutsches Rheuma ForschungsZentrum Berlin, Schumannstr 21 22, 10117 Berlin, Germany
    Ann Rheum Dis 63:836-42. 2004
    ..To estimate the cost of illness in an incidence based cohort of patients with juvenile idiopathic arthritis...
  11. ncbi request reprint [Transition clinic--it is not always a simple segue in rheumatology for adults]
    K Minden
    HELIOS Kliniken, Klinikum Berlin Buch, II Klinik für Kinderheilkunde und Jugendmedizin und Deutsches Rheumaforschungszentrum Berlin, Forschungsbereich Epidemiologie, Schumannstr 21 22, 10117 Berlin, Germany
    Z Rheumatol 64:327-33. 2005
    ..Paediatric and adult rheumatologists should establish close cooperation and implement specific transition programs to meet the special health care needs of these patients...
  12. ncbi request reprint Health care provision in pediatric rheumatology in Germany--national rheumatologic database
    Kirsten Minden
    Epidemiology Unit, German Rheumatism Research Center Berlin
    J Rheumatol 29:622-8. 2002
    ..To describe the health care provision for children and adolescents with chronic arthritides in Germany in 1998...
  13. doi request reprint [Juvenile idiopathic arthritis--clinical subgroups and classification]
    K Minden
    Deutsches Rheumaforschungszentrum Berlin und Universitätskinderklinik, Charite Universitatsmedizin, Campus Virchow Klinikum, Berlin, Deutschland
    Z Rheumatol 67:100, 102-6, 108-10. 2008
    ..A special problem with a need for a solution is represented by the limited application in adult rheumatology...
  14. ncbi request reprint What are the costs of childhood-onset rheumatic disease?
    Kirsten Minden
    German Rheumatism Research Centre Berlin, Rheumatology Unit, Berlin, Germany
    Best Pract Res Clin Rheumatol 20:223-40. 2006
    ..This chapter presents data on the costs of these illnesses, and introduces methodologies and their limitations for cost evaluation within paediatric rheumatology...
  15. doi request reprint Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept
    Jens Klotsche
    German Rheumatism Research Centre Berlin, Leibniz Institute, Berlin, Germany
    Arthritis Care Res (Hoboken) 66:253-62. 2014
    ..We investigated the 12-month course of HRQOL in patients with JIA after the start of therapy with etanercept and identified its determining factors...
  16. ncbi request reprint Comorbidity profiles among adult patients with juvenile idiopathic arthritis: results of a biologic register
    Anna Raab
    German Rheumatism Research Centre Berlin, a Leibniz Institute, Berlin, Germany
    Clin Exp Rheumatol 31:796-802. 2013
    ..This study aims to assess the prevalence of comorbidities in adult JIA and the impact of comorbidity on patients' perceived health state...
  17. doi request reprint Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013
    Jens Klotsche
    German Rheumatism Research Centre Berlin and Charité University Hospital Berlin, Berlin, Germany
    Arthritis Rheumatol 68:3023-3034. 2016
    ..Our study focused on 3-year outcomes in a subsample of patients who were followed up longitudinally...
  18. doi request reprint Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)
    Jens Klotsche
    German Rheumatism Research Centre Berlin, a Leibniz Institute, Berlin, Germany Charité Universitätsmedizin Berlin, Institute for Social Medicine, Epidemiology and Health Economics, Berlin, Germany
    Ann Rheum Dis 75:855-61. 2016
    ..Published evidence on the long-term safety of etanercept (ETA) and adalimumab (ADA) in patients with polyarticular juvenile idiopathic arthritis (pJIA) is still limited...
  19. doi request reprint Effect of methotrexate upon antigen-induced arthritis of the rabbit temporomandibular joint
    Smbat Rafayelyan
    Department of Orthodontics, Dentofacial Orthopedics and Pedodontics, Center for Dental and Craniofacial Sciences, Charite Universitatsmedizin Berlin, Berlin, Germany
    J Oral Pathol Med 44:614-21. 2015
    ..The aim of this study was to investigate the effect of a systemic administration of methotrexate (MTX) on AIA in rabbits by means of three different histological staining methods...
  20. pmc Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database
    Christoph Tappeiner
    German Rheumatism Research Centre Berlin, Leibniz Institute, Berlin, St Franziskus Hospital, Muenster, Germany, and Inselspital, University of Bern, Bern, Switzerland
    Arthritis Care Res (Hoboken) 68:46-54. 2016
    ..Based on a nationwide database, this study analyzed the influence of methotrexate (MTX), tumor necrosis factor (TNF) inhibitors, and a combination of the 2 medications on uveitis occurrence in juvenile idiopathic arthritis (JIA) patients...
  21. doi request reprint Effect of untreated and treated temporomandibular joint arthritis on mandibular volume development in growing rabbits
    Thomas Michael Präger
    Department of Orthodontics, Dentofacial Orthopedics and Pedodontics, Charité Center for Dental, Oral and Maxillofacial Medicine, Charite Universitatsmedizin Berlin, Assmannshauser Str 4 6, 14197, Berlin, Germany
    J Orofac Orthop 76:265-74. 2015
    ....
  22. ncbi request reprint The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set
    Nicolino Ruperto
    Pediatric Rheumatology International Trials Organization PRINTO, IRCCS G Gaslini, Universita di Genova, Pediatria II Reumatologia, Largo Gaslini, Genoa, Italy
    Arthritis Rheum 52:2854-64. 2005
    ..To validate and promulgate a core set of outcome measures for the evaluation of response to treatment in patients with juvenile systemic lupus erythematosus (SLE)...
  23. doi request reprint Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
    Daniel J Lovell
    Cincinnati Children s Hospital Medical Center, Division of Rheumatology, Location E, Rm 2 129, MLC 4010, 3333 Burnet Ave, Cincinnati, OH 45229 3039, USA
    N Engl J Med 359:810-20. 2008
    ..We evaluated the efficacy and safety of adalimumab, a fully human monoclonal anti-TNF antibody, in children with polyarticular-course juvenile rheumatoid arthritis...